Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16399150 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
Condition: Psoriasis
Intervention: Drug: Etanercept

Study has passed its completion date and status has not been verified in more than two years.